Pearce Samantha
Jazz Pharmaceuticals PLC · EVP
Pearce Samantha is listed in public filings as officer: EVP, Chief Commercial Officer. This Pearce Samantha insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Jazz Pharmaceuticals PLC (JAZZ). Investors use Pearce Samantha's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $12M50.3k shares | SellMay 28, 2026 | $1.6M6.9k shares | $235.41 | -- | |
| $06.9k shares | Grant / ExerciseMay 28, 2026 | $756.0K6.9k shares | $109.45 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $9.5M50.3k shares | Grant / ExerciseMar 5, 2026 | $472.3K2.5k shares | $188.69 | -- | |
| --52.8k shares | Grant / ExerciseFeb 26, 2026 | Disclosure amount unavailable9.8k shares | -- | -- | |
| $7.4M43k shares | Grant / ExerciseJan 16, 2026 | $273.7K1.6k shares | $171.16 | -- | |
| --44.6k shares | Grant / ExerciseJan 16, 2026 | Disclosure amount unavailable3.6k shares | -- | -- | |
| $4.7M40.8k shares | Grant / ExerciseAug 5, 2025 | $67.0K577 shares | $116.10 | -- | |
| $5.7M41.2k shares | OtherMar 5, 2025 | $264.7K1.9k shares | $138.95 | -- | |
| --37.4k shares | Grant / ExerciseFeb 27, 2025 | Disclosure amount unavailable11.9k shares | -- | -- | |
| --43.1k shares | Grant / ExerciseFeb 27, 2025 | Disclosure amount unavailable5.8k shares | -- | -- | |
| --26.8k shares | Grant / ExerciseJan 17, 2025 | Disclosure amount unavailable2.5k shares | -- | -- | |
| $3.1M25.4k shares | Grant / ExerciseJan 17, 2025 | $167.4K1.4k shares | $122.62 | -- | |
| --24.1k shares | Grant / ExerciseAug 2, 2024 | Disclosure amount unavailable7k shares | -- | -- |